Thomas M Roberts

USPTO Granted Patents = 8 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 100(Granted Patents)

Company Filing History:

6 out of 1,207

Dana-farber-cancer Institute Inc.

where one patent can have more than one assignee

Years Active: 1982-2022

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11366100 - P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses (2022-06-21),

2. 10960008 - Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents (2021-03-30),

3. 8178317 - Compositions and methods for identifying transforming and tumor suppressor genes (2012-05-15),

4. 6475778 - Differentiation enhancing factors and uses therefor (2002-11-05),

5. 5948758 - Methods for treating various disease states by reducing adhesion of (1999-09-07),

6. 5739032 - Cloning LFA-1 (1998-04-14),

7. 4418149 - Fused hybrid gene (1983-11-29),

8. 4332892 - Protein synthesis (1982-06-01),

Title: Thomas M Roberts: Innovator in Cancer Research

Introduction

Thomas M Roberts is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, holding a total of 8 patents. His work focuses on identifying biomarkers and developing treatment methods for various types of cancers.

Latest Patents

Among his latest patents is the invention related to the P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses. This invention is based on the identification of novel biomarkers that can predict responsiveness to anti-cancer therapies. Another notable patent involves methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3Kbeta and anti-immune checkpoint agents. This invention aims to improve treatment outcomes for patients with specific cancer types.

Career Highlights

Throughout his career, Thomas M Roberts has worked with esteemed institutions such as the Dana-Farber Cancer Institute and Harvard College. His research has significantly advanced the understanding of cancer biology and treatment strategies.

Collaborations

He has collaborated with notable colleagues in the field, including Jean Zhao and Mark S Ptashne. These collaborations have further enriched his research and contributed to the development of innovative cancer therapies.

Conclusion

Thomas M Roberts is a key figure in cancer research, with a strong portfolio of patents that reflect his dedication to improving cancer treatment. His innovative work continues to impact the field and offers hope for better therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.